The effect of withdrawing or continuing anti-hypertensive therapy on orthostatic blood pressure change in elderly hypertensive subjects was examined. Subjects meeting criteria for therapy withdrawal had supine and standing blood pressure measurements taken on treatment, and at 1, 3, 6, 9 and 12 months off treatment whilst receiving standard non-pharmacological advice to lower blood pressure. Subjects not meeting blood pressure criteria for treatment withdrawal or were unwilling to stop treatment had blood pressure measurements taken after 6 and 12 months whilst also receiving non-pharmacological advice. Orthostatic hypotension was defined as a mean systolic blood pressure fall > 20 mmHg on standing from a supine position.
Introduction
It is often assumed that the prevalence of orthostatic hypotension in the elderly is increased by the use of anti-hypertensive agents,-5 although there are reports suggesting such treatment has little effect on orthostatic blood pressure control.6'4 The aims of this study were to assess prospectively the effect of continuing or withdrawing antihypertensive therapy on postural blood pressure control in a group of elderly hypertensive subjects during a one year follow-up period.
Methods

Subjects
Subjects > 65 years with blood pressure < 175/ 100 mmHg who had been on pharmacological treatment for > one year and were currently attending a hospital-based hypertension clinic were asked to participate in a study of treatment withdrawal. All subjects were ambulant and lived at home; those with myocardial infarction or stroke within the preceding 6 months, having angina or known major illnesses were excluded. Also excluded were subjects with diabetes and other diseases known to affect blood pressure, such as Parkinson's disease, or on medication other than anti-hypertensives known to affect blood pressure.
Methods
After 10 minutes supine rest, the mean of three supine and three standing blood pressure measurements, taken 1-3 minutes after standing, were recorded by the same investigator and repeated at three further clinic visits. The mean of the blood pressure measurements on the third visit was taken as the blood pressure level on treatment. All measurements were recorded at least 2 hours after a meal and 6 hours following the last medication using a standard mercury sphygmomanometer and Korotkoff phase V for diastolic blood pres- Table I . For the withdrawal group, the number of subjects having orthostatic hypotension fell significantly from 11 (23%) on antihypertensive treatment to four (11%) (P < 0.05) by 12 months off treatment. In contrast, the group continuing anti-hypertensive therapy showed no Table I , over a 12-month follow-up period off treatment the number of subjects who initially had orthostatic hypotension on treatment fell significantly (P<0.001), while those without orthostatic hypotension on-treatment did not show a significant increase in orthostatic hypotension over the study period. Although orthostatic blood pressure change was related to supine systolic blood pressure at baseline (r = 0.50, P <0.001), this was not so after 12 months offtreatment. In the subjects remaining on therapy, both systolic and diastolic blood pressure were significantly higher (P< 0.05) than in those withdrawn from treatment, although the body mass index, gender, number and type of anti-hypertensive drugs taken were not significantly different between these groups.
Discussion
The effect of anti-hypertensive medications on orthostatic hypotension is unclear. In treated hypertensive patients such medications are often considered responsible for its presence. 1-4 There are reports of a greater prevalence of orthostatic hypotension in persons taking anti-hypertensive medication compared to those not doing so.5
However, many other studies in elderly subjects have reported no significant association between the use of anti-hypertensive agents and postural change in systolic blood pressure, or have related it to the higher systolic blood pressure level in treated hypertensives compared to normotensives.6'10
Harris et al." found the prevalence of orthostatic hypotension in persons not taking anti-hypertensive medication to be 6.6% and for those taking medication 13%, but within each blood pressure stratum the prevalence rates were similar. In the Cardiovascular Health Study, Rutan et al. ' 2 found orthostatic hypotension to be weakly related to the use of beta-blocking and vasodilating agents, but not with diuretics, angiotensin converting enzyme inhibitors or alpha-receptor-blocking agents. Myers et al.'3 also found diuretics, taken for hypertension, cardiac failure and other disorders, to have no effect on the frequency of orthostatic hypotension in the elderly. These studies have, however, compared two separate groups of subjects differing not only with respect to use of anti-hypertensive treatment but also in respect of being either hypertensive or normotensive-a difference reflecting not only blood pressure levels but perhaps also vascular pathology and autonomic functioning'5 and hence orthostatic blood pressure control. '6 Whether currently used anti-hypertensive agents do increase the risk of developing or exacerbating orthostatic hypotension in elderly hypertensive persons has remained unclear. A recent study of 12 elderly patients with systolic hypertension submitted to orthostatic stress on a tilt-table before and one year after 50 mg hydrochlorothiazide daily, found such treatment resulted in no significant hypotensive episodes.'6 However, their subjects were well and without evidence of significant orthostatic hypotension off treatment.
The present study in two groups ofhypertensives suggests that anti-hypertensive therapy based mainly on low-dose thiazide diuretics, betablockers and calcium antagonists does increase the risk ofdeveloping orthostatic hypotension. Despite an increase in systolic blood pressure on withdrawal of pharmacological treatment, the prevalence of orthostatic hypotension fell in the group as a whole and also in those classified as having orthostatic hypotension whilst on treatment. There was, however, considerable variability in the orthostatic blood pressure change within subjects each time blood pressure was measured, a point previously highlighted by Lipsitz et al. ' 7 The non-significantly higher prevalence of orthostatic hypotension in the group on treatment (38%) compared to the withdrawal group whilst on treatment (23%) is probably a reflection of the higher supine systolic blood pressure levels in the former group. The systolic blood pressure levels reported are high compared with the present criteria for initiating anti-hypertensive treatment; this study was, however, started in 1990 pior to the results of three recent trials in elderly hypertensives. [1] [2] The study was too small to detect any differences between type of therapy and presence of orthostatic hypotension, but does suggest it can take many months for any effect of anti-hypertensive therapy on orthostatic hypotension to be abolished following treatment withdrawal.
In conclusion, withdrawal of anti-hypertensive therapy and institution of non-pharmacological treatment can over several months reduce the prevalence of orthostatic hypotension in elderly hypertensive patients. 
